Standard effective doses for proliferative tumours

Physics in Medicine and Biology

Volumn 44, Issue 9, 1999, Pages 2127-2142

  Jones, Lois C ^a,b,d   Metcalfe, Peter ^c   Hoban, Peter ^a   Chris, Fox ^c  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Illawarra Cancer Care Centre   (Australia)

^d LIVERPOOL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CALCULATION; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; SOLID TUMOR;

CELL DIVISION; DOSE FRACTIONATION; HUMANS; LINEAR MODELS; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASMS; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 0032833601     PISSN: 00319155     EISSN: None     Source Type: Journal    
DOI: 10.1088/0031-9155/44/9/302     Document Type: Article

References (35)

1. Antogoni P, Bignardi M, Cazzaniga L F, Poli A, Richetti A, Bossi A, Rampeelo G, Barbera F, Soatti C, Bardelli D, Giordano M and Danova M 1996 Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumour cell kinetics - a phase II multicenter study Int. J. Radiat. Oncol. Biol. Phys. 36 1137-45
2. Barendson G W 1982 Dose fractionation, dose rate and iso-effect relationships for normal tissue responses Int. J. Radiat. Oncol. Biol. Phys. 8 1981-97
3. Barton M 1995 Tables of equivalent dose in 2 Gy fractions: a simple application of the linear quadratic formula Int. J. Radiat. Oncol. Biol. Phys. 31 371-8
4. Begg A C, Moonen L, Hofland I, Dessing M and Bartelink H 1988 Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations Radiother. Oncol. 11 337-47
5. Bentzen S M and Thames H. D 1991 Clinical evidence for tumor clonogen regeneration: interpretations of the data Radiother. Oncol. 22 161-6
6. Bogaert W, Danczak S, Bolla M, Van Glabbeke M and De Pauw M 1992 Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomised trial of the EORTC cooperative group of radiotherapy Radiother. Oncol. 25 231-41
7. Dale R G 1985 The application of the linear quadratic dose effect equation to fractionated and protracted radiation Br J. Radiol. 58 515-28
8. Dische S, Saunders M, Barrett A, Harvey A, Gibson D and Parmar M 1997 A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer Radiother. Oncol. 44 123-36
9. Fowler J F 1989 The linear-quadratic formula and progress in fractionated radiotherapy (review article) Br. J. Radiol. 62 679-94
10. _1990 How worthwhile are short schedules in radiotherapy?: a series of exploratory calculations Radiother. Oncol. 18 165-81
11. Fu K K, Cooper J S, Marcial V A, Laramore G E, Pajak T F, Jacobs J, Al-Sarraf M, Forastiere A A and Cox J D 1996 Evolution of the radiation therapy oncology group clinical trials for head and neck cancer Int. J. Radiat. Oncol. Biol. Phys. 35 425-38
12. Horiot J C, Bontemps P, Van Den Bogaert W, Le Fur R, van den Weijngaert D, Bolla M, Bernier J, Lusinchi A, Stuchke M, Lopez-Torrecilla J, Begg A C, Pierart M and Collette L 1997 Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomised trial Radiother. Oncol. 44 111-21
13. Horiot J C, Le Fur R, N'Guyen T, Chenal C, Schraub S, Alfonsi S, Gardani G, Van Den Bogaert W, Danczak S, Bolla M, Van Glabbeke M and De Pauw M 1992 Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomised trial of the EORTC cooperative group of radiotherpy Radiother. Oncol. 25 231-41
14. Jones B, Tan L T and Dale R G 1995 Derivation of the optimum dose per fraction from the linear quadratic model Br. J. Radiol. 68 894-902
15. Kerr K M and Lamb D 1984 Actual growth rate and tumour cell proliferation in human pulmonary neoplasms Br. J. Can. 50 343-9
16. Koukourakis M, Hlouverakis G, Kosma L, Skarlatos J, Damilakis J, Giatromanolaki A and Yannakakis 1996 The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma Int. J. Radiat. Oncol. Biol. Phys. 34 315-22
17. Lebesque J V and Keus R B 1991 The simultaneous boost technique: the concept of relative normalized total dose Radiother. Oncol. 22 45-55
18. Lee S P, Leu M Y, Smathera J B, McBride W H, Parker R G and Withers R 1995 Biologically effective dose distribution based on the linear quadratic model and its clinical relevance Int. J. Radiat. Oncol. Biol. Phys. 3 375-89
19. Maciejewski B, Skldowski K, Pilecki B, Taylor J M G, Withers R H, Miszczyk L, Zajusz A and Suwinski R 1996 Randomised clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer: preliminary report on acute toxicity Radiother. Oncol. 40 137-45
20. Newcomb C H, Van Dyk J and Hill R P 1993 Evaluation of isoeffect formulae for predicting radiation-induced lung damage Radiother. Oncol. 26 51-63
21. Overgaard J, Sand Hansen H, Sapru W, Overgaard M, Grau C, Jorgensen K, Basthall L, Hansen O, Specht L, Bertgelsen A and Pedersen M 1996 Conventional radiotherapy as the primary treatment of squamous cell carcinoma (SCC) of the head and neck. A randomised multicenter study of 5 versus 6 fractions per week-Preliminary report from the Dahanca 6 and 7 trial Radiother. Oncol. 40 (suppl 1) S31
22. Peters L, Ang K K and Thames H D 1988 Accelerated fractionation in the radiation treatment of head and neck cancer: a critical comparison of different strategies Acta. Oncol. 27 185-94
23. Saunders M I, Dische S, Barrett A, Parmer M K B, Harvey A and Gibson D 1996 Randomised multicentre trials of CHART versus conventional radiotherapy in head and neck and non-small-cell lung cancer Br. J. Cancer 73 1455-62
24. Thames H D and Hendry J H 1987 Fractionation in Radiotherapy (London: Taylor and Francis)
25. Walker Q, Denham J, Hindley A, Lamb D, Poulsen M, Spry N, Tripcony L and Wright J 1996 Multicentre phase III prospective randomised trial of accelerated radiotherapy for locally advanced squamous cell cancer of the head and neck. Interim report Private communication
26. Wang C C 1988 Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes Int. J. Radiat. Oncol. Biol. Phys. 14 1143-6
27. Webb S 1994 Optimum parameters in a model for tumour control probability including interpatient heterogeneity Phys. Med. Biol. 39 1895-914
28. Webb S and Nahum A E 1993 A model for calculating tumour control probability in radiotherapy including the effects of inhomogenoeous distributions of dose and clonogenic cell density Phys. Med. Biol. 38 653-66
29. Wilson G D 1991 Assessment of human tumour proliferation using bromodeoxyuridine - current status Acta Oncol. 30 903-10
30. Wilson G D, McNally N J, Dische S, Saunders M I, Des Rochers C, Lewis A A and Bennett M H 1988. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry Br. J. Cancer 58 423-31
31. Wilson G D, McNally N J, Dunphy E, Karcher H and Pfagner R 1985 The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry Cytometry 6 641
32. Withers H R 1975 The four R's of radiotherapy Adv. Radiat. Biol. 5 241-71
33. Withers H R, Taylor J M and Maciejewski B 1988 The hazard of accelerated tumour clonogen repopulation during radiotherapy Acta. Oncol. 27 131-46
34. Zackrisson B, Gustafsson H, Stenling R, Flygare P and Wilson G D 1997 Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 38 677-83
35. Zagars G K, Schultheiss T E and Peters L J 1987 Inter-tumor heterogeneity and radiation dose-control curves Radiother. Oncol. 8 353-62